Clinical Trials Browser

Interventional × Glioma × Blood Component Removal × Clear all

NCT06964737 2025-10-29

Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas

Phase 1 Recruiting

Glioma

NCT01808820 2022-07-20

Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma

Phase 1 Completed

Astrocytoma, Glioblastoma, Glioma